Recent studies have observed an increase in the rate of pulmonary artery catheter (PAC) use in heart failure admissions. Little is known about the national trends in other previously common indications for PAC placement, PAC use overall, or outcomes associated with PAC placement.
T he benefit of routine pulmonary artery catheterization for critically ill patients was called into question in 1996 by the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments investigators, 1 and subsequent prospective, randomized clinical trials failed to demonstrate clinical benefit in an array of populations. 2 In response to these data, many professional societies updated their guidelines; the American College of Cardiology and American Heart Association (ACC/AHA) now recommend against the use of pulmonary artery catheters (PACs) in routine admissions for heart failure (HF), 3 and the Society of Critical Care Medicine 4 recommends against the routine use of PACs for patients with sepsis-related acute respiratory distress syndrome. The ACC/AHA HF guidelines also contain class I recommendations for PAC use "in patients who have respiratory distress or clinical evidence of impaired perfusion in whom the adequacy of or excess of intracardiac filling pressures cannot be determined from clinical assessment." 3(p167) Recent studies have shown an increase in PAC use in admissions for HF, which raise questions about the rates of use of PACs overall and in other previously common indications for PAC placement. 5, 6 In an effort to evaluate these trends and
given that rates of PAC use have been highest in Americans older than 65 years of age, 7 we analyzed data on PAC use among
Medicare fee-for-service beneficiaries between 1999 and 2013. We also evaluated the outcomes of in-hospital mortality, length of stay, 30-day mortality, 30-day readmission, and 1-year mortality. We also sought to examine trends in PAC use across age, race/ethnicity, and sex to identify any disparities across sociodemographic groups.
Methods
Using Medicare inpatient claims data from the Centers for Medicare and Medicaid Services, we identified all inpatient admissions of fee-for-service beneficiaries 65 years of age or older from January 1, 1999 
Key Points
Question What are the national trends in overall use of pulmonary artery catheters (PACs) and in previously common indications for PAC placement?
Findings In this cohort study of Medicare beneficiaries, rates of PAC use decreased 67.8% from 1999 to 2013, while the rate of PAC use in heart failure admissions decreased from 1999 to 2009, followed by a subsequent increase. Use of PACs in admissions for myocardial infarction and respiratory failure decreased during the study period.
Meaning Overall use of PACs has decreased, and disparate trends have emerged in admissions for heart failure, respiratory failure, and myocardial infarction, raising questions about the drivers of these trends. Table 2 ). The mean (SD) length of stay decreased from 9.1 (9.4) days in 1999 to 6.4 (6.0) days in 2013 (P < .001).
Discussion
Our national study demonstrates a 67.8% decrease in the use of PACs from 1999 to 2013. Despite variation in PAC use across sociodemographic groups, there were significant reductions in use across age, sex, and race/ethnicity. In addition, we report heterogeneity in trends of PAC use across admissions for AMI, HF, and respiratory failure, with substantial and sustained decreases in PAC use for AMI and respiratory failure and a more modest initial decrease for HF with an increase in use more recently. Our findings build on and extend the prior literature, providing the most expansive collection of national data to date on PAC use, as well as assessing length of stay and riskadjusted clinical outcomes. Although there were significant reductions in PAC use overall and across sociodemographic groups, patterns of use across conditions were varied. Consistent with recent analyses from the National Inpatient Sample, 5 Another key finding from our analysis is that, despite patients with PACs having increasing numbers of comorbidities, we observed significant decreases in in-hospital and 30-day mortality. This finding is likely the effect of a selection bias for critically ill patients, a population that has seen similar reductions in mortality, 12 but improved patient selection for PAC placement may play a role as well.
Strengths and Limitations
The validity of our findings is supported by consistent results across several subgroups. More important, similar trends in PAC use described in other studies provide external validity. [5] [6] [7] Our study should be interpreted in the context of the following limitations. First, we studied only fee-for-service Medicare beneficiaries, and findings may not be generalizable to patients who are younger or uninsured. Second, our study relies exclusively on administrative claims data. Our data do not provide the indication for PAC placement or information on the type of unit or hospital, which limits our ability to interpret these trends. Similarly, information on concomitant shock, acute renal failure, and subsequent left ventricular assist device or transplant and outpatient data on inotrope therapies could have provided additional insights into patterns of PAC use, but they were not available. Third, there remains the possibility of a systematic undercoding of PAC use because there are a limited number of fields to document procedure codes, and PAC placement may be "crowded out" in long hospitalizations. However, it is unlikely that this effect significantly changed over time.
Conclusions
In the wake of mounting evidence suggesting a lack of benefit to the routine use of PACs, there has been de-adoption of PAC use overall and across sociodemographic groups but heterogeneity in patterns of use across clinical conditions. These findings raise important questions about their optimal use and the drivers of the observed trends.
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